Product Program year 2021 Source: CMS Open Payments

Kanuma

Drug Immunology

NDC 25682-007-01

Open in the dashboard

General payments

$107,928

1,041 payments

Research payments

$48,353

12 payments

Through program year 2021, $107,928 in general payments and $48,353 in research payments were reported against Kanuma (Immunology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2021 General $13,550 9
2020 General $10,817 30
2019 General $83,561 1,002
2019 Research $48,353 12

Breakdown

Who paid General payments · program years 2019–2021
  1. Alexion Pharmaceuticals, Inc. $107,928 1,041 payments
Top recipients General payments · program year 2021
  1. Manisha Balwani Clinical Genetics (M.D.) · New York, NY $4,800 35% · 3 payments
  2. William Balistreri Pediatric Gastroenterology · Cincinnati, OH $4,375 32% · 3 payments
  3. Donnie Wilson Pediatric Endocrinology · Fort Worth, TX $4,375 32% · 3 payments

Each share is of general payments naming this product in 2021.

Specialties paid General payments · program year 2021
  1. Clinical Genetics (M.D.) Medical Genetics $4,800 35% · 1 practitioner
  2. Pediatric Gastroenterology Pediatrics $4,375 32% · 1 practitioner
  3. Pediatric Endocrinology Pediatrics $4,375 32% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2021
  1. New York $4,800 35% · 1 recipient
  2. Ohio $4,375 32% · 1 recipient
  3. Texas $4,375 32% · 1 recipient

Each share is of general payments naming this product in 2021 where a state was reported.

1,041 general · 12 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record